MedTrace Logo

OrganOx Metra® New Enrollment PAS

NCT05526326 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 315

Last updated 2025-04-03

No results posted yet for this study

Summary

The objective of the OrganOx metra® New Enrollment Post-Approval Study is to collect data on the post-transplant clinical outcomes of DBD and DCD donor livers preserved and assessed on the OrganOx according to the current indications for use in the real-world setting.

Conditions

  • Liver Transplantation

Interventions

DEVICE

Transplant with normothermic machine perfused (NMP) donor liver

The enrolled recipient will receive a DBD or DCD donor liver that underwent normothermic machine perfusion with the OrganOx metra®

Sponsors & Collaborators

  • OrganOx Ltd.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-10
Primary Completion
2025-02-05
Completion
2025-02-05
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05526326 on ClinicalTrials.gov